JP2004531567A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004531567A5 JP2004531567A5 JP2002592909A JP2002592909A JP2004531567A5 JP 2004531567 A5 JP2004531567 A5 JP 2004531567A5 JP 2002592909 A JP2002592909 A JP 2002592909A JP 2002592909 A JP2002592909 A JP 2002592909A JP 2004531567 A5 JP2004531567 A5 JP 2004531567A5
- Authority
- JP
- Japan
- Prior art keywords
- stabilizers
- wetting agents
- liquid solvents
- dispersions
- suspensions
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10125882.8 | 2001-05-28 | ||
| DE10125882A DE10125882B4 (de) | 2001-05-28 | 2001-05-28 | Arzneimittel enthaltend Ambroxol, dessen Salze und/oder Prodrugs zusammen mit α-Liponsäure im Rahmen der Behandlung des Diabetes mellitus |
| PCT/EP2002/005811 WO2002096398A2 (de) | 2001-05-28 | 2002-05-27 | Arzneimittel enthaltend einen effektor des glutathionmetabolismus zussammen mit $g(a)-liponsäure im rahmen der behandlung des diabetes mellitus |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2004531567A JP2004531567A (ja) | 2004-10-14 |
| JP2004531567A5 true JP2004531567A5 (enExample) | 2009-08-20 |
| JP4746258B2 JP4746258B2 (ja) | 2011-08-10 |
Family
ID=7686361
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002592909A Expired - Fee Related JP4746258B2 (ja) | 2001-05-28 | 2002-05-27 | 薬剤 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US7429614B2 (enExample) |
| EP (2) | EP1529529B1 (enExample) |
| JP (1) | JP4746258B2 (enExample) |
| AT (2) | ATE429911T1 (enExample) |
| AU (1) | AU2002344178A1 (enExample) |
| DE (3) | DE10125882B4 (enExample) |
| ES (2) | ES2247377T3 (enExample) |
| PT (1) | PT1529529E (enExample) |
| WO (1) | WO2002096398A2 (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10303229B4 (de) | 2003-01-28 | 2007-07-26 | Keyneurotek Ag | Ambroxol und Inhibitoren des Angiotensin Converting-Enzyms (ACE) umfassende Arzneimittel Arzneimittel-Zubereitung und ihre Verwendung zur Behandlung von neurodegenerativen Erkrankungen |
| DE10360954B3 (de) * | 2003-12-23 | 2005-08-18 | Esparma Gmbh | Verwendung von Silibinin, dessen Salzen und/oder dessen Prodrugs zusammen mit α-Liponsäure zur Behandlung chronisch obstruktiver Lungenerkrankungen |
| US20090176864A1 (en) * | 2004-11-24 | 2009-07-09 | Hill's Pet Nutrition, Inc. | Methods For Improving Hepatic and Immune Function In An Animal |
| JP5785355B2 (ja) * | 2004-11-24 | 2015-09-30 | ヒルズ・ペット・ニュートリシャン・インコーポレーテッド | 動物における生体異物物質の肝臓クリアランスを改良する方法 |
| US20100099751A1 (en) * | 2008-10-21 | 2010-04-22 | Al-Mulla Fahd | Method of treating diabetes-related vascular complications |
| KR20110103987A (ko) * | 2008-12-01 | 2011-09-21 | 인베이스크 테라퓨틱, 인크. | 레닌-안지오텐신 알도스테론계 억제제 및 리포산 화합물을 포함하는 조성물, 및 레닌-안지오텐신 알도스테론계 관련 질환의 치료를 위한 이의 용도 |
| CN113244265B (zh) * | 2021-03-23 | 2023-07-14 | 武汉广行科学研究有限公司 | 配体修饰的硫化锌纳米粒子、制备方法及其在治疗中的应用 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH03169813A (ja) * | 1989-11-09 | 1991-07-23 | Asta Pharma Ag | 細胞保護作用を有する疼痛及び炎症性疾患及び／又はレトロウイルスに起因する病気の治療用医薬並びにその製法 |
| DE4218572A1 (de) * | 1992-06-05 | 1993-12-09 | Asta Medica Ag | Synergistische Kombination von Arzneimitteln enthaltend als Wirkstoff alpha-Liponsäure, Dihydroliponsäure, deren Metaboliten sowie die oxidierten und reduzierten Enantiomere der alpha-Liponsäure wie die R-alpha-Liponsäure oder S-alpha-Liponsäure sowie Metaboliten der alpha-Liponsäure mit den Vitaminen A, B1-6, B12, C und E |
| DE4343593C2 (de) * | 1993-12-21 | 1998-05-20 | Asta Medica Ag | Verwendung von R-(+)-alpha-Liponsäure, R-(-)-Dihydroliponsäure oder der Metabolite sowie deren Salze, Ester, Amide zur Behandlung kompensierter und dekompensierter Insulinresistenz |
| DE4420102A1 (de) * | 1994-06-09 | 1995-12-14 | Asta Medica Ag | Arzneimittelkombinationen aus alpha-Liponsäure und herz-kreislaufaktiven Substanzen |
| GB9715444D0 (en) * | 1997-07-22 | 1997-09-24 | Scotia Holdings Plc | Therapeutic and dietary compositions |
| US6133304A (en) * | 1997-12-23 | 2000-10-17 | Warner-Lambert Company | ACE inhibitor-MMP inhibitor combinations |
| DE19806354B4 (de) * | 1998-02-10 | 2004-09-16 | Bdd Group Holding Ag | Verwendung von α-Liponsäure oder deren physiologisch verträgliche Salze zur Behandlung von LDL-Hypercholesterinämie |
| JP2000309543A (ja) * | 1999-04-28 | 2000-11-07 | Ajinomoto Co Inc | 抗糖尿病剤 |
| DE10125883A1 (de) * | 2001-05-28 | 2002-12-12 | Serumwerk Bernburg Ag | Arzneimittel enthaltend einen Effektor des Glutathionmetabolismus zusammen mit alpha-Liponsäure im Rahmen der Nierenersatztherapie |
-
2001
- 2001-05-28 DE DE10125882A patent/DE10125882B4/de not_active Expired - Fee Related
-
2002
- 2002-05-27 ES ES02774028T patent/ES2247377T3/es not_active Expired - Lifetime
- 2002-05-27 EP EP04027492A patent/EP1529529B1/de not_active Expired - Lifetime
- 2002-05-27 DE DE50204093T patent/DE50204093D1/de not_active Expired - Lifetime
- 2002-05-27 AU AU2002344178A patent/AU2002344178A1/en not_active Abandoned
- 2002-05-27 WO PCT/EP2002/005811 patent/WO2002096398A2/de not_active Ceased
- 2002-05-27 ES ES04027492T patent/ES2322257T3/es not_active Expired - Lifetime
- 2002-05-27 EP EP02774028A patent/EP1392288B1/de not_active Expired - Lifetime
- 2002-05-27 AT AT04027492T patent/ATE429911T1/de not_active IP Right Cessation
- 2002-05-27 DE DE50213511T patent/DE50213511D1/de not_active Expired - Lifetime
- 2002-05-27 US US10/478,174 patent/US7429614B2/en not_active Expired - Fee Related
- 2002-05-27 PT PT04027492T patent/PT1529529E/pt unknown
- 2002-05-27 AT AT02774028T patent/ATE303145T1/de active
- 2002-05-27 JP JP2002592909A patent/JP4746258B2/ja not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2006044362A3 (en) | N-sulfonylpiperidine cannabinoid receptor 1 antagonists | |
| WO2003087094A3 (en) | Pyrrolidinium derivatives as antagonists of m3 muscarinic receptors | |
| JP2006507281A5 (enExample) | ||
| IL164222A0 (en) | Oral pharmaceutical formulation in the form of aqueous suspension for modified release of active principle(s) | |
| DE602004024375D1 (de) | Carboxamidderivate | |
| CA2521509A1 (en) | Fast dissolving orally consumable films containing pharmaceutically active agents | |
| AU2003262262A1 (en) | Pyrazole derivatives, medicinal composition containing the same, and medicinal use thereof | |
| PL1758914T3 (pl) | Nowe fluoroglikozydowe pochodne pirazoli, leki zawierające te związki i ich zastosowanie | |
| CA2462606A1 (en) | Orally administered liquid compositions comprising guaifenesin and a polyoxyalkylene block copolymer | |
| DE602005025083D1 (enExample) | ||
| WO2006073419A3 (en) | Lipoprotein nanoplatforms | |
| JP2002511411A5 (enExample) | ||
| ATE275393T1 (de) | Feste dispersionen mit nitrataktiven wirkstoffen | |
| TW200716202A (en) | Pediatric formulation of topiramate | |
| JP2007537301A5 (enExample) | ||
| WO2006116148A3 (en) | (7-arlysubstituted 2, 3-dihydr0-1-benz0furan-2-yl) alkylamines in the treatment' of substance abuse | |
| WO2003053945A3 (en) | Urea derivatives and their use as vanilloid receptor antagonists | |
| JP2004531567A5 (enExample) | ||
| WO2004043362A3 (en) | Acyl guanidine compounds and use thereof | |
| WO2009004792A1 (ja) | スルホンアミド化合物及びその結晶 | |
| IL181216A (en) | 5, 3-SICO-4-NORKOLSTAN DERIVATIVES AND PHARMACEUTICAL COMPONENTS CONTAINING @ THEM | |
| WO2005046689A3 (fr) | Utilisation d’un derive du pyrazole pour la prevention et le traitement des dyslipidemies et des maladies associees aux dyslipidemies et/ou a l’obesite | |
| DE60202590D1 (de) | 2h-1-benzopyran-derivate, prozesse zu ihrer herstellung und pharmazeutische zusammensetzungen | |
| WO2004000219A3 (en) | Stabilized formulations of alpha adrenergic receptor antagonists and uses thereof | |
| JPWO2019246633A5 (enExample) |